The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking
here.
The global human papillomavirus (HPV) vaccine market was valued at approximately USD 3.80 billion in 2019 and is expected to grow significantly, reaching around USD 12.69 billion by 2027. This growth corresponds to a compound annual growth rate (CAGR) of 16.3% over the forecast period. North America led the market in 2019, holding the largest share at 48.16%.
Published by
Rucha Deo,
2025-06-13 02:29:09
Human Papillomavirus (HPV) Vaccines Market Future Scope, Investment Trends, and Forecast to 2032
The global human papillomavirus (HPV) vaccine market was valued at approximately USD 3.80 billion in 2019 and is expected to grow significantly, reaching around USD 12.69 billion by 2027. This growth corresponds to a compound annual growth rate (CAGR) of 16.3% over the forecast period. North America led the market in 2019, holding the largest share at 48.16%.
Keywords: Human Papillomavirus (HPV) Vaccine Market
Click to View FlipBook Version